You are currently viewing Characterization of biomarkers 2 years following vaccination with oral cholera vaccine: a prospective observational study

Characterization of biomarkers 2 years following vaccination with oral cholera vaccine: a prospective observational study

Project Summary

This research constitutes the long-term follow-up of participants enrolled in our Oral Cholera Vaccine Simplified (OCV-S) study conducted two years ago. During the OCV-S study, participants were administered either Euvichol-S or ShancholTM vaccines. In this observational study, a single visit is performed for the eligible and interested participants of our previous OCV-S study. The participants are asked about any recent illnesses, with particular attention to enteric illnesses. Additionally, blood samples are obtained to analyze a variety of biomarkers, which will indicate their baseline immune status before and after vaccination.
 

Study Duration

From December 2023

 

Objectives

To characterize immunologic biomarkers among vaccinated individuals from Euvichol-S Phase 3 trial. To describe the frequency of participants with evidence of recent past (the last 12 months) Vibrio cholerae infection based on immunologic biomarkers. To describe the frequency of self-reported diarrheal illness in the past 12 months.

Team Members

Principal Investigator(s): Dr. Dipesh Tamrakar, Prof. Dr. Rajeev Shrestha

Co-Investigator(s): Dr. Srijana Dangol, Dr. Shristi Jonchhe, Dr. Samita Adhikary, Dr. Mukul Upadhyaya Nepal, Dr. Sanket Kumar Mishra, Mr. Surendra Kumar Madhup

Project Coordinator: Dr. Shristi Jonchhe

Research Assistants: Ms.Reena Kharbuja, Ms. Menuka Dawadi, Ms. Sampada GC, Ms. Sona Gautam, Ms. Anusha Basnet, Ms. Laxmi Shova Hakuduwal, Ms. Sarita Gosain

Supported Partner: International Vaccine Institute

Collaborating Partners: International Vaccine Institute (IVI)

For more detailed Information, Please contact:  rajeev.shrestha@kusms.edu.np / rmaleku@hotmail.com or dipesht@kusms.edu.np